Top Life Science Consulting Firms
Nominate a Company
Usually, the qualified subscribers of our magazine nominate companies with whom they have collaborated and experienced exceptional results to be in this list. Did a company you recently worked with give you stellar results and ROI? Did it turn out to be one you would wholeheartedly recommend to peers? Or do you know of such an outstanding company through your network? Please fill in the details below and nominate them to be featured here.
Top Life Science Consulting Firms
Life Science Consulting News
How Pharmaceutical War Games Move from Insight to Action
Wednesday, October 21, 2026
Pharmaceutical competition now unfolds across more than brand-versus-brand positioning. Franchise priorities, portfolio choices, corporate commitments and a wider set of stakeholders than the commercial team alone can shape a launch. That changes what a war game has to accomplish. A useful simulation cannot stop at predicting a rival’s next move. It has to help teams decide what game they intend to play and where they can influence the market before launch. The session must also narrow down the actions that deserve resources once the workshop ends. Simulation design is therefore a major buying factor. Standard templates can make workshops easier to run, but they may
Buyers Place Greater Weight on Practical Experience When Choosing Advanced Therapy Advisors
Wednesday, August 12, 2026
Scientific expertise remains a core requirement when selecting an advisory firm, but it is no longer the only factor shaping buying decisions in the advanced therapies sector. Development teams are asking more practical questions before bringing in outside consultants. They want to understand whether an advisory firm can help guide real development decisions, not simply provide technically sound recommendations that are difficult to put into practice. That change reflects the nature of advanced therapy development. Programs typically move through several stages, requiring close coordination between research, manufacturing and quality teams. Decisions made in one area often affec
Advanced Therapy Developers Turn to Advisory Firms Earlier in the Development Process
Wednesday, August 12, 2026
A manufacturing decision made at the wrong stage or an incomplete development plan can slow an advanced therapy program long before it reaches patients. For organisations developing cell therapies, gene therapies and other complex treatments, many technical questions emerge well before commercial manufacturing enters the picture. That is changing when developers decide to bring consulting and advisory firms into the process. More developers are involving external advisors during the early stages of development instead of waiting until major project milestones. The conversation has also shifted. Rather than asking consultants to solve a single technical issue, many organisations
Long-Term Planning Shapes Demand for Advanced Therapies Advisory Services
Wednesday, August 12, 2026
Advanced therapy programs rarely move from research to commercialisation in a straight line. A decision made during the early stages of development can have consequences for manufacturing plans or project timelines much later. That reality is changing how organisations think about advisory services. Rather than bringing in outside experts only when issues arise, many developers are making advisory support part of their long-term planning. Scientific development and manufacturing are closely linked in advanced therapies. Choices made early in a program can affect later work in ways that are not always obvious at the time. Because of that, developers are increasingly turning to ad
Transaction Execution Risk: A Major Focus in Life Science Transactions
Thursday, July 02, 2026
Transactions that seem interesting during their initial phases are not uncommon. In life sciences financing events, partnerships and other strategic transactions, transaction execution risk remains a major consideration. The above issue is fueling the growth of the advisory and strategic investment banking services in the industry. The businesses understand that, besides finding opportunities, the ability to manage transactions is crucial in achieving success. Most of the life sciences transactions require a lot of preparatory work. Information collection, due diligence activities, and stakeholder communication may be time-consuming tasks that may slow down a transacti
Conditions for Funding Prompt Early Strategic Planning for Life Sciences Businesses
Thursday, July 02, 2026
Even if there is an interesting scientific project, its financing may be challenging, as there is a tendency for companies to start their planning too late in terms of financial aspects. Today, the discussion on capital raising in the life sciences industry is linked to the company's corporate strategy. Therefore, there is a great need for strategic investment banking solutions. Life sciences businesses develop for a very long time. Therefore, research programs, development and commercialization of products require a lot of money well before any income is generated. In such situations, it is hard to choose between financing options. However, the problem is not only
